What is the interpretation and management of an estimated Glomerular Filtration Rate (GFR) of 82 ml/min/1.73m^2 in a patient with potential Chronic Kidney Disease (CKD)?

Interpretation of eGFR 82 mL/min/1.73m²

An eGFR of 82 mL/min/1.73m² falls within the normal to mildly decreased kidney function range (CKD stage G2 if albuminuria is present, or normal if no other kidney damage markers exist) and does not require specific CKD interventions unless albuminuria or other kidney damage is documented. 1

Clinical Classification

• This eGFR value is above the 60 mL/min/1.73m² threshold that defines chronic kidney disease based on GFR alone 1, 2
• Normal GFR ranges are approximately 100-130 mL/min/1.73m² in young men and 90-120 mL/min/1.73m² in young women, with physiological decline after age 40 1
• An eGFR of 60-89 mL/min/1.73m² represents mildly decreased kidney function but may be completely normal for older adults 1
• GFR >60 mL/min/1.73m² does NOT exclude kidney disease if other markers of damage are present, such as albuminuria or structural abnormalities on imaging 1

Essential Next Steps

You must assess for albuminuria to determine if CKD is present:

• Measure urine albumin-to-creatinine ratio (UACR) in a random spot urine collection 3
• CKD requires either eGFR <60 mL/min/1.73m² OR evidence of kidney damage (albuminuria, structural abnormalities) persisting ≥3 months 1
• If UACR is normal and no other kidney damage markers exist, this patient does not have CKD despite the eGFR being below the theoretical "young adult normal" range 1, 2

Risk Stratification Based on Albuminuria

If albuminuria is present, the patient should be classified using the KDIGO heat map system combining GFR category (G2 at this eGFR) with albuminuria category (A1-A3): 4, 5

• A1 (UACR <30 mg/g): Low risk - routine monitoring
• A2 (UACR 30-300 mg/g): Moderate risk - requires intervention
• A3 (UACR >300 mg/g): High risk - aggressive management needed

Management Recommendations

For patients WITHOUT albuminuria or other kidney damage:

• No CKD-specific interventions required 1
• Address cardiovascular risk factors as appropriate for the general population
• Repeat eGFR annually if risk factors present (diabetes, hypertension, family history)

For patients WITH diabetes and albuminuria (any level):

• Initiate SGLT2 inhibitor if eGFR ≥20 mL/min/1.73m² to reduce CKD progression and cardiovascular events 3, 6
• Add metformin if eGFR ≥30 mL/min/1.73m² 6
• Consider GLP-1 receptor agonist if glycemic targets not met with metformin and SGLT2i 6
• Target blood pressure 140/90 mmHg 5

For patients WITH albuminuria ≥300 mg/g:

• Target ≥30% reduction in UACR to slow CKD progression 3
• Consider ACE inhibitor or ARB (but not both together) 5

Monitoring Strategy

Frequency of eGFR and albuminuria monitoring should increase with severity of kidney disease: 4

• At this eGFR level with normal albuminuria: annual monitoring is sufficient
• With albuminuria present: every 3-6 months depending on severity
• A decline of ≥5 mL/min/1.73m² per year indicates rapid progression requiring intensified management 4

Critical Pitfalls to Avoid

• Do not diagnose CKD based on a single eGFR measurement - requires persistence ≥3 months 1
• Never use serum creatinine alone without calculating GFR 1
• Extremes of muscle mass, acute illness, recent surgery, or hydration status can produce inaccurate eGFR estimates 1
• An eGFR >60 mL/min/1.73m² does NOT exclude kidney disease - always check for albuminuria 1, 2
• The CKD-EPI equation (which you used) is more accurate than older MDRD equations, especially at eGFR levels >60 mL/min/1.73m² 7

When to Refer to Nephrology

Nephrology referral is NOT indicated at this eGFR level unless: 3, 5

• Rapidly progressive decline in kidney function
• Uncertainty about etiology of kidney disease
• UACR >60 mg/mmol (approximately >530 mg/g) or proteinuria >1 g/day 5
• eGFR drops below 30 mL/min/1.73m² 3, 5